Risk of Hepatitis B Virus (HBV) reactivation in patients found to be Hepatitis B surface antigen negative/ antibody to the Hepatitis B core antigen positive and the role of routine anti-viral prophylaxis. Letter to Editor: In Reply. Journal of Clinical Oncology 2009; 27(15):2570-1
Publication in refereed journal

Full Text

Other information
All Author(s) ListYEO Winnie, LEUNG W Y, CHAN T C, CHAN Kay Sheung Paul
Journal nameJournal of Clinical Oncology
Volume Number15
Issue Number27
PublisherAmerican Society of Clinical Oncology
Place of PublicationUnited States of America
LanguagesEnglish-United Kingdom
KeywordsHBV; antigen

Last updated on 2018-19-01 at 04:53